Analyst firms · Daiwa · JNJ
Daiwa JNJ price target and rating history
Johnson & Johnson (JNJ) · Health Care
Daiwa rates Johnson & Johnson (JNJ) Outperform with a $203 price target, as of its latest action on Oct 20, 2025. It has published 3 rating actions on JNJ since June 2022, including 1 upgrade and 1 downgrade. Across 4 firms with a JNJ price target in the last 12 months, the median target is $263.50.
- Current rating
- Outperform
- Price target
- $203
- Median target, all firms
- $263.50
- Actions on JNJ
- 3
Daiwa price target on JNJ
Every Daiwa rating on JNJ
- Oct 20, 2025
- Jul 23, 2024
- Jun 22, 2022
How other firms rate JNJ
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Erste Group | Hold | Oct 21, 2026 | |
| UBS | Buy | $320 | Sep 2, 2026 |
| Leerink Partners | Outperform | $265 | May 13, 2026 |
| TD Cowen | Buy | $250 | Apr 8, 2026 |
| Morgan Stanley | Overweight | $262 | Jan 28, 2026 |
Questions about Daiwa and JNJ
- What is Daiwa's price target for JNJ?
- Daiwa's latest stated price target for Johnson & Johnson (JNJ) is $203, from its action on Oct 20, 2025.
- What is Daiwa's rating on JNJ?
- Daiwa rates JNJ Outperform, a bullish rating, as of Oct 20, 2025.
- When did Daiwa last change its view on JNJ?
- On Oct 20, 2025, Daiwa upgrades to Outperform from Neutral, price target $203.
- How does Daiwa's JNJ target compare with other analysts?
- Across 4 firms with a JNJ price target in the last 12 months, the median target is $263.50.
More JNJ rating histories
All Daiwa ratingsJNJ news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.